GM2 gangliosides are a group of lysosomal lipid storage disorders that resulted from disease-causing mutations in three autosomal recessive genes, including hexosaminidase A (HEXA), hexosaminidase subunit beta (HEXB) and GM2 ganglioside activator (GM2A). Here, HEXB is linked to lysosomal lipid storage disorder.